Neurocrine Biosciences, Inc. (NBIX)
135.79
+0.22
(+0.16%)
USD |
NASDAQ |
Jan 09, 16:00
135.77
-0.02
(-0.01%)
After-Hours: 20:00
Neurocrine Biosciences Total Liabilities (Quarterly): 1.262B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Masimo Corp. | 1.008B |
| Insulet Corp. | 1.645B |
| Marker Therapeutics, Inc. | 3.346M |
| CapsoVision, Inc. | 5.219M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.266B |
| Shareholders Equity (Quarterly) | 3.004B |
| Debt to Equity Ratio | 0.1597 |
| Current Ratio | 3.383 |
| Net Debt Paydown Yield | -0.27% |